Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Northwest Biotherapeutics (NWBO) Dividends Paid - Common: 2009-2013

Historic Dividends Paid - Common for Northwest Biotherapeutics (NWBO) over the last 2 years, with Dec 2013 value amounting to $1.3 million.

  • Northwest Biotherapeutics' Dividends Paid - Common changed negligibly% to $1.3 million in Q4 2013 from the same period last year, while for Dec 2013 it was $2.5 million, marking a year-over-year decrease of 50.00%. This contributed to the annual value of -$1.3 million for FY2009, which is N/A change from last year.
  • As of Q4 2013, Northwest Biotherapeutics' Dividends Paid - Common stood at $1.3 million, which was down 0.00% from $1.3 million recorded in Q3 2013.
  • In the past 5 years, Northwest Biotherapeutics' Dividends Paid - Common registered a high of $1.3 million during Q2 2010, and its lowest value of -$1.3 million during Q1 2009.
  • In the last 3 years, Northwest Biotherapeutics' Dividends Paid - Common had a median value of $1.3 million in 2013 and averaged $938,250.
  • Data for Northwest Biotherapeutics' Dividends Paid - Common shows a maximum YoY tumbled of 200.00% (in 2013) over the last 5 years.
  • Over the past 5 years, Northwest Biotherapeutics' Dividends Paid - Common (Quarterly) stood at -$1.3 million in 2009, then remained steady at $1.3 million in 2010, then remained steady at $1.3 million in 2011, then remained steady at $1.3 million in 2012, then remained steady at $1.3 million in 2013.
  • Its last three reported values are $1.3 million in Q4 2013, $1.3 million for Q3 2013, and -$1.3 million during Q2 2013.